$High dose cyclophosphamide for severe refractory myasthenia gravis$

High dose cyclophosphamide for severe refractory myasthenia gravis

Materials and methods All patients participated in studies approved by the Drexel University College of Medicine and signed informed consent. Drachman et al reported a decline in antibody levels in their patients treated in a similar way, although AChr antibody titres and MuSK antibodies persisted i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2004-05, Vol.75 (5), p.789-791
Hauptverfasser:	Gladstone, D E, Brannagan, T H, Schwartzman, R J, Prestrud, A A, Brodsky, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Amputation Cyclophosphamide - administration & dosage Cyclophosphamide - therapeutic use Drug Administration Schedule Drug Resistance Dysphagia high dose cyclophosphamide Humans Intubation Letter Male myasthenia gravis Myasthenia Gravis - drug therapy Neutropenia Patients Severity of Illness Index Stem cells Steroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!